Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-23-021286

Options or other derivatives

  • Vice Pres Sales & Marketing acquired 5,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bitterman Chris T. Vice Pres Sales & Marketing 2023-03-24 Grant or award · Options (right to buy) +5,500 12,500 D
Loading xslF345X04/doc4.xml…